biocon (Citi) Mixed Quarter; Axicorp Divestment a Positive

Mixed Quarter; Good growth in 4Q, barring Germany; EBIDTA miss but lower tax aides bottom-line; Strong revenue & profitability in FY11; welcome course correction on Axicorp
Date Rating Target Price Recommendation Price Broker house
28 Apr 2011 hold 480 376 Citi Report

No comments:

Post a Comment